EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Novel benzene sulfonamides with acetylcholinesterase and carbonic anhydrase inhibitory actions

Rafika El Ati, Necla Öztaşkın, Ahmet Çağan, Akın Akıncıoğlu, Yeliz Demir, Süleyman Göksu, Rachid Touzani, İlhami Gülçin

Archiv der Pharmazie · 2024

DOI: 10.1002/ardp.202300545 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archiv der Pharmazie, 2024. Verfasst von Rafika El Ati und 7 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Applied Chemistry and Environment (LCAE), Faculty of Sciences, University Mohammed the first, Oujda, Morocco. Hauptthemen laut MEDLINE: Carbonic Anhydrase Inhibitors, Cholinesterase Inhibitors, Sulfonamides, Acetylcholinesterase. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Ataturk University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A series of benzene sulfonamides 15–26 were synthesized and determined for their in vitro and in silico inhibitory profiles toward acetylcholinesterase (AChE) and carbonic anhydrases (CAs). Commercially available 3,4‐dimethoxytoluene was reacted with chlorosulfonic acid to furnish benzene sulfonyl chloride derivatives. The reaction of substituted benzene sulfonyl chloride with some amines also including (±)‐α‐amino acid methyl esters afforded a series of novel benzene sulfonamides. In this study, the enzyme inhibition abilities of these compounds were evaluated against AChE and CAs. They exhibited a highly potent inhibition ability on AChE and ‐CAs ( K i values are in the range of 28.11 ± 4.55 nM and 145.52 ± 28.68 nM for AChE, 39.20 ± 2.10 nM to 131.54 ± 12.82 nM for CA I, and 50.96 ± 9.83 nM and 147.94 ± 18.75 nM for CA II). The present newly synthesized novel benzene sulfonamides displayed efficient inhibitory profiles against AChE and CAs, and it is anticipated that they may emerge as lead molecules for some diseases including glaucoma, epilepsy, and Alzheimer's disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carbonic Anhydrase InhibitorsCholinesterase InhibitorsSulfonamidesAcetylcholinesteraseStructure-Activity RelationshipMolecular StructureMolecular Docking SimulationHumansCarbonic AnhydrasesDose-Response Relationship, DrugBenzenesulfonamidesBenzene

Stichwörter der Autor:innen

acetylcholinesterasebenzene sulfonamidescarbonic anhydraseenzyme inhibition

Substanzen

Carbonic Anhydrase InhibitorsCholinesterase InhibitorsSulfonamidesAcetylcholinesteraseCarbonic AnhydrasesBenzenesulfonamidesBenzene

Autor:innen und Institutionen

  • Laboratory of Applied Chemistry and Environment (LCAE), Faculty of Sciences, University Mohammed the first, Oujda, Morocco.
  • Department of Chemistry, Faculty of Science, Atatürk University, Erzurum, Turkiye.
  • Central Researching Laboratory, Agri Ibrahim Cecen University, Agri, Turkiye.
  • Vocational School, Ağrı İbrahim Çeçen University, Agri, Turkiye.
  • Department of Pharmacy Services, Ardahan University, Ardahan, Turkiye.

Förderung

  • Ataturk University

Zitieren

APA

El Ati, R., Öztaşkın, N., Çağan, A., Akıncıoğlu, A., Demir, Y., Göksu, S., Touzani, R., & Gülçin, İ. (2024). Novel benzene sulfonamides with acetylcholinesterase and carbonic anhydrase inhibitory actions. Archiv der Pharmazie. https://doi.org/10.1002/ardp.202300545

Vancouver

El Ati R, Öztaşkın N, Çağan A, Akıncıoğlu A, Demir Y, Göksu S, et al. Novel benzene sulfonamides with acetylcholinesterase and carbonic anhydrase inhibitory actions. Archiv der Pharmazie. 2024. doi:10.1002/ardp.202300545

BibTeX
@article{ElAti2024,
  author = {El Ati, Rafika and Öztaşkın, Necla and Çağan, Ahmet and Akıncıoğlu, Akın and Demir, Yeliz and Göksu, Süleyman and Touzani, Rachid and Gülçin, İlhami},
  title = {Novel benzene sulfonamides with acetylcholinesterase and carbonic anhydrase inhibitory actions},
  journal = {Archiv der Pharmazie},
  year = {2024},
  doi = {10.1002/ardp.202300545}
}
Kostenlos starten →